During the epidemic, patients with tumors have represented a very special patient group. A study that specifically targeted 1590 patients with NCP with previous medical records in 575 hospitals found that there were 18 patients with a history of cancer.
Compared with NCP patients without cancer, NCP patients with a history of cancer were older (63.1 vs 48.7 years), and a higher proportion of NCP patients with cancer had a history of smoking (22.2% vs 6.8%), shortness of breath (47.1% vs 23.5%), or severe symptoms according to computed tomography (CT) imaging (94.4% vs 70.8%).
More importantly, the study found that patients with tumors had a higher risk of developing severe disease than did nontumor patients. Moreover, for all comorbidities, patients with a cancer history had the highest risk of severe disease. In addition, researchers also found that tumor patients with NCP worsened faster than did nontumor patients (median time from onset to severe symptoms was 13 days vs 43 days, P < .001).
Therefore, the research team proposed three strategies for patients with tumors during the NCP outbreak and other possible epidemics of severe infectious diseases in the future: first, in endemic areas, for clinically stable patients with tumors, delayed chemotherapy or elective surgery should be considered; second, patients with tumors and cancer survivors should strengthen their personal protection; and third, if patients with tumors are infected with SARS‐CoV‐2, especially elderly patients or patients with other comorbidities, extra monitoring or treatment should be provided for priority treatment.
Treatment and procedure of head and neck surgery during the epidemic period
[Color figure can be viewed at wileyonlinelibrary.com]
近年来科室在《Clin Cancer Res》、《Br J Cancer 》、《Oncogene》、《Carcinogenesis》、《Int J Cancer》国内、外知名肿瘤期刊公开发表头颈肿瘤专业论文数百余篇，SCI收录130余篇，头颈肿瘤防治研究成果获省、市级科技成果奖13项，获得国家自然科学基金立项资助8项，获国家、省市级科研经费资助500余万元，获国家知识产权局授权头颈外科专利技术30余项。作为指南起草人，起草参编了国内首部《分化型甲状腺癌诊治指南》,《持续/复发及转移性分化型甲状腺癌诊治指南》及《甲状腺外科ERAS中国专家共识》多部甲状腺癌全国指南及专家共识，这些工作为我省以及西南地区头颈肿瘤防治事业做出了积极的贡献。